Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-8,300
Closed -$1.35M 201
2015
Q4
$1.35M Sell
8,300
-6,000
-42% -$943K 0.07% 150
2015
Q3
$1.98M Sell
14,300
-2,000
-12% -$315K 0.11% 128
2015
Q2
$2.5M Buy
16,300
+15,300
+1,530% +$2.45M 0.15% 121
2015
Q1
$160K Buy
+1,000
New +$157K 0.01% 183

Other funds holding AMGN

CMT Asset Management's AMGN Position: Q4 2015 in Review

CMT Asset Management sold out of Amgen (AMGN) in Q4 2015, closing a stake of 4,323 shares — an estimated $680K sold.

CMT Asset Management first reported a position in AMGN in Q2 2015 and held it in 2 quarters. The position peaked at $1.45M in Q2 2015. 1,453 funds tracked by Wall St. Rank hold AMGN as of Q4 2015.

  • CMT Asset Management reported no remaining Amgen position as of Q4 2015 after selling out during the quarter.
  • CMT Asset Management sold 4,323 Amgen shares in Q4 2015, an estimated $680K.
  • CMT Asset Management first reported a position in Amgen in Q2 2015 and held it in 2 quarters.
  • CMT Asset Management's Amgen position peaked at $1.45M in Q2 2015.
  • 1,453 funds tracked by Wall St. Rank held Amgen as of Q4 2015.

Based on CMT Asset Management's 13F filing for Q4 2015, filed 17 Feb 2016.